Winolog Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a nutritional supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analogue of essential amino acids, designed to provide the necessary precursors for protein synthesis while minimizing nitrogenous waste accumulation. This mechanism helps reduce the metabolic burden on impaired kidneys, thereby slowing the progression of renal dysfunction. Winolog Tablet is typically administered alongside a controlled low-protein diet to optimize nitrogen balance and mitigate uremic symptoms. Its use is indicated in patients with moderate to severe CKD, particularly those approaching end-stage renal disease or undergoing conservative management to delay dialysis initiation. The tablet should be taken as prescribed by a healthcare professional, with dosage adjustments based on renal function and nutritional status. Commonly, Winolog is well tolerated; however, monitoring for electrolyte imbalances and adherence to dietary recommendations is essential to maximize therapeutic benefits. It is contraindicated in patients with hypersensitivity to any component of the formulation. Winolog Tablet represents an important adjunct in renal nutritional therapy, aiming to improve patient outcomes by preserving residual kidney function and enhancing quality of life in CKD management.